Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin
Authors
Keywords
-
Journal
Molecular Oncology
Volume 9, Issue 9, Pages 1799-1814
Publisher
Wiley
Online
2015-06-16
DOI
10.1016/j.molonc.2015.06.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts
- (2015) Pragya Srivastava et al. Epigenetics
- SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
- (2015) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
- (2014) R M Glasspool et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epigenetic Targeting of Ovarian Cancer Stem Cells
- (2014) Yinu Wang et al. CANCER RESEARCH
- The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer
- (2014) F. Fang et al. CLINICAL CANCER RESEARCH
- SGI-110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome
- (2014) Carmen S. Tellez et al. INTERNATIONAL JOURNAL OF CANCER
- Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts
- (2014) Pragya Srivastava et al. LEUKEMIA RESEARCH
- Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status
- (2014) Shikha Gaur et al. Molecular Cancer
- MethHC: a database of DNA methylation and gene expression in human cancer
- (2014) Wei-Yun Huang et al. NUCLEIC ACIDS RESEARCH
- Targeting the Wnt/β-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535
- (2014) Roberto Gedaly et al. PLoS One
- Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report
- (2014) Hui Fan et al. Journal of Immunology Research
- Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy
- (2013) M. Selvakumaran et al. CLINICAL CANCER RESEARCH
- Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer
- (2013) Z.-l. Zeng et al. CLINICAL CANCER RESEARCH
- Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
- (2013) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
- (2013) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA
- (2013) Michelle T. Paulsen et al. METHODS
- Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response
- (2013) M. T. Paulsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Survivin – biology and potential as a therapeutic target in oncology
- (2013) Jang-Yang Chang et al. OncoTargets and Therapy
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
- (2012) A. Lachenmayer et al. CLINICAL CANCER RESEARCH
- Pathways and targets in hepatocellular carcinoma
- (2012) Amanda Psyrri et al. Expert Review of Anticancer Therapy
- Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors
- (2012) Olaf Neumann et al. HEPATOLOGY
- Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma
- (2012) Naoshi Nishida et al. HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Structure-Based Mechanistic Insights into DNMT1-Mediated Maintenance DNA Methylation
- (2012) J. Song et al. SCIENCE
- Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma
- (2012) Masahiro Shitani et al. TUMOR BIOLOGY
- Aberrant methylation ofSPARCin human hepatocellular carcinoma and its clinical implication
- (2012) Ye Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation
- (2011) Adam S. Bodzin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
- (2011) Ronan J Kelly et al. Molecular Cancer
- A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
- (2010) S. Roessler et al. CANCER RESEARCH
- IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage
- (2010) Victoria Tovar et al. JOURNAL OF HEPATOLOGY
- S110, a 5-Aza-2'-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
- (2010) J. C. Chuang et al. MOLECULAR CANCER THERAPEUTICS
- A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas
- (2009) T. Bekaii-Saab et al. CLINICAL CANCER RESEARCH
- Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
- (2009) C. Desbois-Mouthon et al. CLINICAL CANCER RESEARCH
- The promises and pitfalls of epigenetic therapies in solid tumours
- (2009) Janet S. Graham et al. EUROPEAN JOURNAL OF CANCER
- Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
- (2009) Haluk Yuzugullu et al. Molecular Cancer
- Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma
- (2009) Hong Fan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma
- (2008) Anne F. Buckley et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started